author-photo

Zeyang Li

Huazhong University of Science and Technology

4

Papers

9

Citations

Citation Trend

Filter By

Papers (3) Sort By

Journal Conference Others

TJ-M2010-5, a novel MyD88 inhibitor, corrects R848-induced lupus-like immune disorders of B cells in vitro.

2020 International Immunopharmacology
Show All
- Source
- Cite
- Save
Citations (1)
The MyD88 inhibitor TJ-M2010-2 suppresses proliferation, migration and invasion of breast cancer cells by regulating MyD88/GSK-3β and MyD88/NF-κB signalling pathways.

2020 Experimental Cell Research
Show All
- Source
- Cite
- Save
Citations (2)
Short-term use of MyD88 inhibitor TJ-M2010-5 prevents d-galactosamine/lipopolysaccharide-induced acute liver injury in mice

2019 International Immunopharmacology
Show All
- Source
- Cite
- Save
Citations (6)